ATOVAQUONE ORAL SUSPENSION

Atovaquone oral suspension · PAI Holdings, LLC dba PAI Pharma

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ATOVAQUONE ORAL SUSPENSION, covering 2019-05-31 to 2022-11-22. Get the full timeline:

Most recent: FDA Approved: ATOVAQUONE ORAL SUSPENSION — Supplemental Application (KVK-Tech, Inc.)